These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 7911400

  • 21. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 22. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ.
    J Assoc Acad Minor Phys; 2000 Sep; 11(1):7-11. PubMed ID: 10826019
    [Abstract] [Full Text] [Related]

  • 23. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.
    Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, Halvorsen L, Stallemo A, Hovdenak N, Trondstad R.
    Scand J Gastroenterol; 1993 Mar; 28(3):224-8. PubMed ID: 8446846
    [Abstract] [Full Text] [Related]

  • 24. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 25. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 27. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M, Pospai D, Forestier S, Vatier J, Vallot T.
    Clin Ther; 1993 Sep; 15 Suppl B():22-31. PubMed ID: 8205592
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I, Sagar M, Sjöstedt S, Hammarlund B, Iwarzon M, Seensalu R.
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [Abstract] [Full Text] [Related]

  • 29. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T, Horikoshi T, Nishioka T, Kusano M.
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [Abstract] [Full Text] [Related]

  • 30. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N.
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [Abstract] [Full Text] [Related]

  • 31. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 32. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB.
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [Abstract] [Full Text] [Related]

  • 33. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S, Santucci L, Morelli A.
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [Abstract] [Full Text] [Related]

  • 34. Drugs, bugs, and esophageal pH profiles.
    Robinson M.
    Yale J Biol Med; 1999 Nov; 72(2-3):169-72. PubMed ID: 10780578
    [Abstract] [Full Text] [Related]

  • 35. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [Abstract] [Full Text] [Related]

  • 36. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS, Rowley JL.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [Abstract] [Full Text] [Related]

  • 37. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D.
    Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
    [Abstract] [Full Text] [Related]

  • 38. Omeprazole: a new approach to gastric acid suppression.
    Buhl K, Clearfield HR.
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [Abstract] [Full Text] [Related]

  • 39. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S, Iida T, Tabata T, Kishikawa H, Tanaka Y.
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [Abstract] [Full Text] [Related]

  • 40. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
    Franco MT, Salvia G, Terrin G, Spadaro R, De Rosa I, Iula VD, Cucchiara S.
    Dig Liver Dis; 2000 Nov; 32(8):660-6. PubMed ID: 11142573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.